# Coya Therapeutics, Inc.: Form 8-K, filed May 12, 2026

- Company: [Coya Therapeutics, Inc.](/companies/coya.md) (CIK 1835022)
- Form: 8-K
- Filed: 2026-05-12
- Accepted by EDGAR: May 12, 2026, 07:39 ET
- Period: 2026-05-12
- Accession: 0001193125-26-218198
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1835022/000119312526218198/coya-20260512.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1835022/000119312526218198/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1835022/000119312526218198/coya-20260512.htm

Filed May 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-218198. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.
